These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 13165939)

  • 1. Benign (favorable) types of brain tumor; the and results (up to twenty years), with statistics of mortality and useful survival.
    HORRAX G
    N Engl J Med; 1954 Jun; 250(23):981-4. PubMed ID: 13165939
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of surgical cases of intraparenchymal metastatic brain tumors from solid tumors; analysis for prognostic factors associated with survival].
    Nakagawa H; Kimura S; Nakajima Y; Izumoto S; Hayakawa T
    No Shinkei Geka; 1992 Feb; 20(2):115-21. PubMed ID: 1542389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric follow up of brain metastases: a useful method to evaluate treatment outcome and predict survival after Gamma Knife surgery?
    Feigl GC; Horstmann GA
    J Neurosurg; 2006 Dec; 105 Suppl():91-8. PubMed ID: 18503338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Storm HH; Klint A
    Acta Oncol; 2010 Jun; 49(5):673-93. PubMed ID: 20192877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery.
    Monaco E; Kondziolka D; Mongia S; Niranjan A; Flickinger JC; Lunsford LD
    Cancer; 2008 Nov; 113(9):2610-4. PubMed ID: 18780313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast.
    Amendola BE; Wolf AL; Coy SR; Amendola M; Bloch L
    Cancer J; 2000; 6(2):88-92. PubMed ID: 11069225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The end results in favorable types of brain tumor; a brief summary.
    HORRAX G
    Lahey Clin Bull; 1955 Apr; 9(4):98-100. PubMed ID: 14382494
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term survival in patients with brain metastases.
    Lutterbach J; Bartelt S; Ostertag C
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):417-25. PubMed ID: 12200598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for patients with brain tumors.
    Gehan EA; Walker MD
    Natl Cancer Inst Monogr; 1977 Dec; 46():189-95. PubMed ID: 349395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiologic characteristics of mortality in the most common malignant tumors of the head and neck in Serbia].
    Sokić S; Sokić M; Mitrović P
    Med Pregl; 1993; 46(7-8):276-9. PubMed ID: 7968825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and management of intracranial ependymomas.
    Papadopoulos DP; Giri S; Evans RG
    Anticancer Res; 1990; 10(3):689-92. PubMed ID: 2369084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain tumors in infants].
    Guilburd JN; Lapras C; Guyotat J
    Harefuah; 1989 Feb; 116(3):133-5. PubMed ID: 2714691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors.
    Forseen SE; Potti A; Koka V; Koch M; Fraiman G; Levitt R
    Anticancer Res; 2002; 22(3):1599-602. PubMed ID: 12168843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosurgery for brain metastases from unknown primary cancers.
    Niranjan A; Kano H; Khan A; Kim IY; Kondziolka D; Flickinger JC; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1457-62. PubMed ID: 20056342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.
    Davis FG; McCarthy BJ; Freels S; Kupelian V; Bondy ML
    Cancer; 1999 Jan; 85(2):485-91. PubMed ID: 10023719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors.
    Nishizaki T; Saito K; Jimi Y; Harada N; Kajiwara K; Nomura S; Ishihara H; Yoshikawa K; Yoneda H; Suzuki M; Gibbs IC
    Minim Invasive Neurosurg; 2006 Aug; 49(4):203-9. PubMed ID: 17041830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
    Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multimodality treatment of malignant brain tumors].
    Takakura K; Shitara N; Nakamura H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):959-64. PubMed ID: 2730036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.